Cell line development and cell culture optimization face a new era with the introduction of knowledge-driven genomics based on new technologies such as NGS and omics-based approaches.
Harald Bradl, Ph.D.
Director, Cell Culture and Process Sciences
Boehringer Ingelheim
Our customers now have available a computational platform that supports our market-leading TLA technology and enables them to significantly increase the number of clones analyzed, thereby increasing the efficiency of their quality control and cell line development workflow.
To optimally handle the complex data, we need a centralized genome knowledge management and analysis solution that addresses the interdisciplinary challenges in the next-generation biotechnology innovations.
Harald Bradl, Ph.D.
Director, Cell Culture and Process Sciences
Boehringer Ingelheim
With Genedata Selector we can integrate a wide range of complex R&D-relevant data and make the data easily accessible within our globally distributed R&D organization.
Dr. Jari Vehmaanperä
Global R&D Director
AB Enzymes